(BN) Brookfield - Ratings and Ratios
Exchange: NYSE • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA11271J1075
BN: Real Estate, Infrastructure, Energy, Ventures, Equity, Assets
Brookfield Corporation, trading under the ticker symbol BN on the NYSE, is a distinguished alternative asset manager and Real Estate Investment Trust (REIT). Established in 1997 and headquartered in Toronto, Canada, Brookfield has cultivated a robust presence with offices spanning North and South America, Europe, the Middle East, and Asia. Their expertise lies in managing a diverse array of assets, including real estate, renewable energy, infrastructure, and private equity, catering to both institutional and retail investors.
Their investment strategy is marked by a focus on sectors rich in real assets, which are often undervalued and possess significant potential for cash flow generation. This includes industrial and building materials, mining, and oil and gas. Brookfields approach emphasizes operational improvements and strategic restructuring, aiming to unlock latent value in underperforming assets. Their equity investments range from $2 million to $500 million, reflecting their agility in addressing various market opportunities.
Geographically, Brookfields reach is extensive, with concentrated efforts in North America, Brazil, Europe, and Australia. This diversification not only mitigates risk but also positions them to capitalize on emerging global trends. Their funds typically operate on a four-year investment period with a ten-year term, extendable by two years, allowing ample time for value realization. Brookfields commitment to disciplined investing and active management underscores their reputation as a reliable partner for investors seeking exposure to real assets.
Financially, Brookfields market capitalization exceeds $91 billion, with a price-to-earnings ratio of 194.77, indicating significant growth expectations. Their forward P/E of 15.77 and price-to-book ratio of 2.09 suggest a balanced approach to valuation. With a price-to-sales ratio of 0.93, they demonstrate prudent management of their revenue streams. For more insights, visit their website at https://bn.brookfield.com.
Additional Sources for BN Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BN Stock Overview
Market Cap in USD | 91,076m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Asset Management & Custody Banks |
IPO / Inception | 1983-12-30 |
BN Stock Ratings
Growth 5y | 58.8% |
Fundamental | -41.8% |
Dividend | 24.6% |
Rel. Strength Industry | 14.1 |
Analysts | 3.75/5 |
Fair Price Momentum | 60.64 USD |
Fair Price DCF | - |
BN Dividends
Dividend Yield 12m | 0.59% |
Yield on Cost 5y | 0.96% |
Annual Growth 5y | -3.68% |
Payout Consistency | 95.8% |
BN Growth Ratios
Growth Correlation 3m | 19.8% |
Growth Correlation 12m | 94.1% |
Growth Correlation 5y | 57.6% |
CAGR 5y | 11.94% |
CAGR/Max DD 5y | 0.24 |
Sharpe Ratio 12m | 1.38 |
Alpha | 16.61 |
Beta | 1.51 |
Volatility | 29.01% |
Current Volume | 3479.1k |
Average Volume 20d | 1997.7k |
As of February 22, 2025, the stock is trading at USD 58.86 with a total of 3,479,086 shares traded.
Over the past week, the price has changed by -3.38%, over one month by -1.64%, over three months by +2.45% and over the past year by +48.35%.
Probably not. Based on ValueRay Fundamental Analyses, Brookfield (NYSE:BN) is currently (February 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -41.78 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BN as of February 2025 is 60.64. This means that BN is currently overvalued and has a potential downside of 3.02%.
Brookfield has received a consensus analysts rating of 3.75. Therefor, it is recommend to hold BN.
- Strong Buy: 2
- Buy: 4
- Hold: 1
- Sell: 0
- Strong Sell: 1
According to ValueRays Forecast Model, BN Brookfield will be worth about 67.8 in February 2026. The stock is currently trading at 58.86. This means that the stock has a potential upside of +15.14%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 66.1 | 12.4% |
Analysts Target Price | 63.7 | 8.2% |
ValueRay Target Price | 67.8 | 15.1% |